Veradigm Inc. Files 8-K on Material Agreement
| Field | Detail |
|---|---|
| Company | Veradigm Inc. |
| Form Type | 8-K |
| Filed Date | Aug 20, 2025 |
| Risk Level | medium |
| Pages | 5 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.01, $50.00, $32.00 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, regulation-fd
TL;DR
Veradigm inked a big deal, filing an 8-K on 8/20/25. Details TBD.
AI Summary
Veradigm Inc. filed an 8-K on August 20, 2025, reporting an entry into a material definitive agreement. The filing also covers material modifications to the rights of security holders and Regulation FD disclosures. Specific details of the agreement and its financial implications are not provided in this excerpt.
Why It Matters
This filing indicates a significant new agreement for Veradigm Inc., which could impact its business operations, financial standing, and shareholder rights.
Risk Assessment
Risk Level: medium — The filing indicates a material definitive agreement, which inherently carries risks related to its execution and impact, but specific details are not yet available.
Key Players & Entities
- Veradigm Inc. (company) — Registrant
- August 20, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
FAQ
What is the nature of the material definitive agreement entered into by Veradigm Inc.?
The provided excerpt does not specify the nature of the material definitive agreement, only that one was entered into on or before August 20, 2025.
What are the key terms and financial implications of this agreement?
The excerpt does not contain details regarding the key terms or financial implications of the agreement.
How might this agreement modify the rights of Veradigm Inc.'s security holders?
The filing indicates material modifications to the rights of security holders, but the specific changes are not detailed in this excerpt.
Are there any Regulation FD disclosures associated with this filing?
Yes, the filing explicitly lists 'Regulation FD Disclosure' as an item information, suggesting public disclosure of previously non-public information.
What was Veradigm Inc.'s former name?
Veradigm Inc. was formerly known as ALLSCRIPTS HEALTHCARE SOLUTIONS, INC., ALLSCRIPTS-MISYS HEALTHCARE SOLUTIONS, INC., and ALLSCRIPTS HEALTHCARE SOLUTIONS INC.
Filing Stats: 1,354 words · 5 min read · ~5 pages · Grade level 9.4 · Accepted 2025-08-20 16:12:32
Key Financial Figures
- $0.01 — ich registered Common Stock, par value $0.01 per share MDRX N/A (OTC Expert Mark
- $50.00 — nior Participating Preferred Stock from $50.00 to $32.00 (and made other conforming ch
- $32.00 — cipating Preferred Stock from $50.00 to $32.00 (and made other conforming changes to t
Filing Documents
- d95615d8k.htm (8-K) — 35KB
- d95615dex46.htm (EX-4.6) — 17KB
- d95615dex991.htm (EX-99.1) — 11KB
- g95615g0820235533270.jpg (GRAPHIC) — 4KB
- 0001193125-25-184086.txt ( ) — 187KB
- mdrx-20250820.xsd (EX-101.SCH) — 2KB
- mdrx-20250820_lab.xml (EX-101.LAB) — 17KB
- mdrx-20250820_pre.xml (EX-101.PRE) — 11KB
- d95615d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits: Exhibit No. Description 4.1 Stockholder Rights Agreement, dated as of February 26, 2024, by and between the Company and Broadridge Corporate Issuer Solutions, LLC, as rights agent (which includes the Form of Rights Certificate as Exhibit B thereto) (incorporated by reference to Exhibit 4.1 to the Company's Form 8-A, filed on February 27, 2024) 4.2 Amendment No. 1 to Stockholder Rights Agreement, dated as of May 10, 2024, by and between the Company and Broadridge Corporate Issuer Solutions, LLC, as rights agent (incorporated by reference to Exhibit 4.2 to the Company's Form 8-K, filed on May 13, 2024) 4.3 Amendment No. 2 to Stockholder Rights Agreement, dated as of February 13, 2025, by and between the Company and Broadridge Corporate Issuer Solutions, LLC, as rights agent (incorporated by reference to Exhibit 4.3 to the Company's Form 8-K, filed on February 20, 2025) 4.4 Amendment No. 3 to Stockholder Rights Agreement, dated as of February 20, 2025, by and between the Company and Broadridge Corporate Issuer Solutions, LLC, as rights agent (incorporated by reference to Exhibit 4.4 to the Company's Form 8-K, filed on February 20, 2025) 4.5 Amendment No. 4 to Stockholder Rights Agreement, dated as of March 18, 2025, by and between the Company and Broadridge Corporate Issuer Solutions, LLC, as rights agent (incorporated by reference to Exhibit 4.5 to the Company's Form 8-K, filed on March 18, 2025) 4.6 Amendment No. 5 to Stockholder Rights Agreement, dated as of August 20, 2025, by and between the Company and Broadridge Corporate Issuer Solutions, LLC, as rights agent 99.1 Press Release issued by Veradigm Inc. on August 20, 2025 regarding Amendments to Stockholder Rights Agreement 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. VERADIGM INC. Date: August 20, 2025 By: /s/ Eric Jacobson Name: Eric Jacobson Title: Senior Vice President, Deputy General Counsel and Corporate Secretary